Objective. To study the association between psychological gender and adherence to immunomodulatory therapy in patients with multiple sclerosis. Material and methods. Thirty-four patients (25 women and 9 men) with the diagnosis of multiple sclerosis were examined. The following methods were used: MMSE, The Bem Sex Role Inventory adapted in Russia, Beck Depression Inventory, State-Trait Anxiety Inventory. During three months patients reported the first and the last immunomodulator injections dates from every new pack. Then the patients’ self-reports systematization and analysis were performed, drug-taking compliance and timing compliance were calculated. Results and conclusion. Twenty-eight patients had an androgynous type of psychological gender and six persons were feminine. The association was determined between high compliance and such psychological gender peculiarities as a significantly large number of feminine traits than masculine ones and the low number of masculine characteristics in men.